Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
06. September 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care06. September 2024 Eversheds Sutherland has advised Edwards Lifesciences on the US$4.2bn sale of its Critical Care product group to Becton, Dickinson and Company (BD). Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The Critical Care product group is an industry leader in advanced patient monitoring with advanced AI algorithms serving millions of patients globally. Ansprechpartner
Lee Harris Partner London, Vereinigtes Königreich Antony Walsh Partner London, Vereinigtes Königreich Barri Mendelsohn Partner London, Vereinigtes Königreich Rachel Cooper Partner Nottingham, Vereinigtes Königreich Edward M. Tompkin-Haag Partner London, Vereinigtes Königreich Kelly Holmes Partner Birmingham, Vereinigtes Königreich Philip Crosbie Partner Leeds, Vereinigtes Königreich Christopher Murray Partner Edinburgh, Vereinigtes Königreich Publikationen
News
Events und Trainings
client news 02. Juni 2026 Next stop, public ownership: Eversheds Sutherland advises DfT on GTR transi... kanzlei-news 01. Juni 2026 Shaping the Future kanzlei-news 01. Juni 2026 Eversheds Sutherland strengthens restructuring offering with senior partner... kanzlei-news 01. Juni 2026 Eversheds Sutherland strengthens Commercial Advisory practice with technolo... virtual Spanish employment law training 02. Juni 2026 2pm - 5pm (BST) Virtual virtual UK employment law training 09. Juni 2026 1pm - 4pm (BST) Virtual virtual Nordic (Denmark, Finland, Norway and Sweden) employment law training 16. Juni 2026 12.45pm - 4pm (BST) Virtual virtual Webinar: Conquering the US Market 23. Juni 2026 17.00-18.00 |